HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TNF-α-induced down-regulation of CDX2 suppresses MEP1A expression in colitis.

AbstractBACKGROUND/AIMS:
High levels of pro-inflammatory cytokines are linked to inflammatory bowel disease (IBD). The transcription factor Caudal-related homeobox transcription factor 2 (CDX2) plays a crucial role in differentiation of intestinal epithelium and regulates IBD-susceptibility genes, including meprin 1A (MEP1A). The aim was to investigate the expression of CDX2 and MEP1A in colitis; to assess if they are regulated by tumor necrosis factor-α (TNF-α), and finally to reveal if CDX2 is involved in a TNF-α-induced down-regulation of MEP1A.
METHODS:
Expression of CDX2 and MEP1A was investigated in colonic biopsies of ulcerative colitis (UC) patients and in dextran sodium sulfate (DSS)-induced colitis. CDX2 protein expression was investigated by immunoblotting and immunohistochemical procedures. CDX2 and MEP1A regulation was examined in TNF-α-treated Caco-2 cells by reverse transcription-polymerase chain reaction and with reporter gene assays, and the effect of anti-TNF-α treatment was assessed using infliximab. Finally, in vivo CDX2-DNA interactions were investigated by chromatin immunoprecipitation.
RESULTS:
The CDX2 and MEP1A mRNA expression was significantly decreased in active UC patients and in DSS-colitis. Colonic biopsy specimens from active UC showed markedly decreased CDX2 staining. TNF-α treatment diminished the CDX2 and MEP1A mRNA levels, a decrease which, was counteracted by infliximab treatment. Reporter gene assays showed significantly reduced CDX2 and MEP1A activity upon TNF-α stimulation. Finally, TNF-α impaired the ability of CDX2 to interact and activate its own, as well as the MEP1A expression.
CONCLUSIONS:
The present results indicate that a TNF-α-mediated down-regulation of CDX2 can be related to suppressed expression of MEP1A during intestinal inflammation.
AuthorsMehmet Coskun, Anders Krüger Olsen, Thomas Lindebo Holm, Peter Helding Kvist, Ole Haagen Nielsen, Lene Buhl Riis, Jørgen Olsen, Jesper Thorvald Troelsen
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1822 Issue 6 Pg. 843-51 (Jun 2012) ISSN: 0006-3002 [Print] Netherlands
PMID22326557 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 Elsevier B.V. All rights reserved.
Chemical References
  • Antibodies, Monoclonal
  • CDX2 Transcription Factor
  • CDX2 protein, human
  • Homeodomain Proteins
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Dextran Sulfate
  • Infliximab
  • Metalloendopeptidases
  • meprin A
Topics
  • Adult
  • Animals
  • Antibodies, Monoclonal (pharmacology)
  • CDX2 Transcription Factor
  • Cell Line
  • Chromatin Immunoprecipitation
  • Colitis, Ulcerative (chemically induced, genetics, metabolism, pathology)
  • Dextran Sulfate
  • Female
  • Homeodomain Proteins (biosynthesis, genetics)
  • Humans
  • Inflammatory Bowel Diseases (genetics, metabolism, pathology)
  • Infliximab
  • Intestinal Mucosa (metabolism)
  • Male
  • Metalloendopeptidases (biosynthesis, genetics)
  • Mice
  • Middle Aged
  • RNA, Messenger (genetics, metabolism)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: